Free radical intermediates of phenytoin and related teratogens. Prostaglandin H synthase-catalyzed bioactivation, electron paramagnetic resonance spectrometry, and photochemical product analysis.
about
Teratogenic mechanisms of medical drugsOxidative stress, unfolded protein response, and apoptosis in developmental toxicityTeratogenic effects of thalidomide: molecular mechanisms.Anticonvulsant activity, teratogenicity and pharmacokinetics of novel valproyltaurinamide derivatives in miceReduced 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-initiated oxidative DNA damage and neurodegeneration in prostaglandin H synthase-1 knockout mice.Drug bioactivation, covalent binding to target proteins and toxicity relevance.Minimising the potential for metabolic activation in drug discovery.Pathways of carbamazepine bioactivation in vitro. III. The role of human cytochrome P450 enzymes in the formation of 2,3-dihydroxycarbamazepine.Lipid peroxidation in women with epilepsyFetal oxidative stress mechanisms of neurodevelopmental deficits and exacerbation by ethanol and methamphetamine.Non-cytochrome P450-mediated bioactivation and its toxicological relevance.Enhanced NADPH oxidases and reactive oxygen species in the mechanism of methanol-initiated protein oxidation and embryopathies in vivo and in embryo culture.Deficient DNA repair exacerbates ethanol-initiated DNA oxidation and embryopathies in ogg1 knockout mice: gender risk and protection by a free radical spin trapping agent.Co-variation in frequency and severity of cardiovascular and skeletal defects in Sprague-Dawley rats after maternal administration of dimethadione, the N-demethylated metabolite of trimethadione.
P2860
Q22337136-B7E13311-29A8-47F8-A924-3E8A8F496C81Q28084613-DFAE40FD-1719-41B1-8229-4E30D7F4209CQ34660391-8AB23BF3-37B5-4A13-93CE-0B92C02D12D8Q35045414-6390262B-4E96-453B-AB87-4CEF1CB5C1E7Q36012329-F7286146-F113-40CB-BCB9-9716090E8F59Q36061821-F0172D70-9D57-4861-9E9D-921B2C624856Q36572637-154B0786-D772-4A62-B658-6C495A9ED4C8Q36926122-22F6DAD2-7DD6-46DE-ACD0-B1A54EAE616EQ37430150-2841A837-93FD-46EA-B6FC-D5D8C5581FB8Q38877279-8217D620-91B2-4777-A406-8F182FD1CF94Q38929936-4E1258A5-4F19-46F6-A5B3-4CDF0507D089Q42702420-BA537664-1B9F-475B-88A4-79BD2EB19F01Q42703738-FEACE961-1494-4920-B2DA-CAECEC609DC5Q51865316-4B65B759-92FC-4CF6-ACDE-CCD9F6F47438
P2860
Free radical intermediates of phenytoin and related teratogens. Prostaglandin H synthase-catalyzed bioactivation, electron paramagnetic resonance spectrometry, and photochemical product analysis.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Free radical intermediates of ...... hotochemical product analysis.
@en
Free radical intermediates of ...... hotochemical product analysis.
@nl
type
label
Free radical intermediates of ...... hotochemical product analysis.
@en
Free radical intermediates of ...... hotochemical product analysis.
@nl
prefLabel
Free radical intermediates of ...... hotochemical product analysis.
@en
Free radical intermediates of ...... hotochemical product analysis.
@nl
P2093
P2860
P356
P1476
Free radical intermediates of ...... hotochemical product analysis.
@en
P2093
P2860
P304
25079-25088
P356
10.1074/JBC.273.39.25079
P407
P577
1998-09-01T00:00:00Z